Ptt 大爆卦 | Adenovirus vector - 前往 https://www.businesswire.com/news/home/20230823459614/en/Royalty-Pharma-and-Ferring-Pharmaceuticals-Enter-into-US-500-million-Royalty-Agreement-for-New-Intravesical-Gene-Therapy-Adstiladrin%C2%AE-nadofaragene-firadenovec-vncg

你即將離開本站

並前往https://www.businesswire.com/news/home/20230823459614/en/Royalty-Pharma-and-Ferring-Pharmaceuticals-Enter-into-US-500-million-Royalty-Agreement-for-New-Intravesical-Gene-Therapy-Adstiladrin%C2%AE-nadofaragene-firadenovec-vncg

Royalty Pharma and Ferring Pharmaceuticals Enter into US ...

Adstiladrin is a non-replicating adenovirus vector-based gene therapy for the treatment of adult patients with high-risk BCG-unresponsive NMIBC.

確定！回上一頁

查詢「Adenovirus vector」的人也找了：